Skip to main content

SwiftPharma is a Belgium-based biotech startup that develops plant-based solutions for protein production for critical medical applications. SwiftPharma is led by Jeroen Hofenk, the Chief Science Officer with expertise in molecular biology and genetics. The organization uses tobacco plants as bioreactors to produce recombinant proteins such as vaccines, monoclonal antibodies, enzymes, antiviral and antibacterial agents. “Our process is a fusion of plant biology, agrobacteria, vacuum infiltration and a touch of molecular science,” Jeroen says.

By working with Medace, SwiftPharma is taking important steps towards scaling up their production and ensuring quality and compliance with Good Manufacturing Practices (GMP). Within Medace’s cleanroom facility, they have manufactured a virus inhibitor protein for preventing HIV transmission. They are also working on a biosimilar protein for reducing the cost of oncology treatments.

SwiftPharma demonstrated a strong focus on creating impact and advancing global health with their innovative technologies. They received interest and funding from the National Institutes of Health and the Population Council in the US for their HIV prevention project, which aims to rewrite the possibilities in healthcare. They were also approached by a competitor company and the Brazilian Ministry of Health, to provide scalable GMP production for their biosimilar project, which can reduce the cost of an existing oncology product by 80%.

As the projects advance, SwiftPharma is ready to scale up production in Medace’s cleanroom environment.

Medace’s support goes beyond facilities and includes quality systems and regulatory compliance. “Medace’s involvement was crucial; their help contributed to securing the contract with the National Institute and the Population Council. It built trust that the auditors came to a professional partner with solid explanations and full transparency,” Jeroen said.

Medace and SwiftPharma’s collaboration is a partnership and a commitment to creating impact with plant-based proteins. As Jeroen puts it, “This collaboration is about thinking in possibilities, and Medace is our trusted partner on this journey.”

 

“It built trust that the auditors came to a professional partner like Medace that offers solid explanations and full transparency.”

– Jeroen Hofenk (Chief Science Officer SwiftPharma)

 

About SwiftPharma

SwiftPharma is a Belgium-based biotech startup that develops plant-based solutions for protein production for critical medical applications. The technological platform, HyperXpress, is market disruptive and stands for a paradigm shift in sustainable biomanufacturing. SwiftPharma’s vision is to become the dominant global provider of unique plant-based products suited for healthcare challenges. SwiftPharma is a privately held company headquartered in Leuven, Belgium.

Get in touch

Contact Us - Cleanroom rental
First
Last

Training interest

Training interest
Name
Name
First
Last

Training registration

Training registration
I agree with the terms and conditions *

Brochure - MD

Training registration

Training registration
I agree with the terms and conditions *

Training interest

Register interest for training course

Get in touch

Call me back